CHAPEL HILL, N.C., May 16, 2014 /PRNewswire/ --The Medical Affairs function plays a critical role in meeting current challenges within the health care sector. Indeed, most healthcare professionals agree that the Medical Affairs function takes on an enormous role in guiding the sector's ongoing transition from simply drug marketing, to dealing with a wide range of stakeholders who influence market access. The Medical Affairs Consortium at Best Practices, LLC is dedicated to providing benchmarking and best practices across critical Medical Affairs functions including, but not limited to: Medical Information / Communication, Scientific / Medical Liaisons, Thought Leader Services, Health Outcomes & Data Management and Medical Education.
The Medical Affairs Consortium brings Medical Affairs executives together to focus on learning and sharing best practices regarding their key issues. Consortium members participate in a three-part study that they help in the creation of the theme. Following the completion of this study, members get three-part customized analysis that contains a specific report comparing the member companies to the benchmark class. In addition, we host three virtual roundtables that allow members to share, question, listen, seek ideas from peers and discuss challenges that confront them after each study part. Specifically, benefits include:
- Participation in 3-part research study series on Medical Affairs Excellence
- Access to the Best Practices Database and its wealth of Medical Affairs content
- Virtual briefings and roundtables that include Medical Affairs executives from leading companies
- 3 report deliverables created from the consortium study and shared with members throughout the year
- Customized gap analysis within each report
- Access to Best Practices' research advisors
Best Practices, LLC is hosting its third 2013-2014 Medical Affairs Roundtable on Thursday, June 5 to discuss how to create effective strategies in thought leader management. Companies participating in the third roundtable include: Amgen, Astellas, Astra Zeneca, Baxter, Biogen Idec, Eli Lilly, Genentech, Merck, Novartis, Pfizer, ProStrakan, Sanofi, Upsher-Smith and Teva. Our third roundtable will be the end of the first Medical Affairs Consortium and the second consortium will kick off in early July.
For more information regarding the Medical Affairs Consortium studies, please review our Weekly Medical Affairs Consortium Research Release.
To learn more about Medical Affairs Consortium, click on the following link:http://www.best-in-class.com/medical-affairs-consortium
For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website athttp://www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
SOURCE Best Practices, LLC
